edgen-logo

AI Copilot
portfolioPortfolio

Stocks

Crypto

News
StocksCrypto

Chat History

Aura
Follow our

Join our

EN
Back

Avidity Biosciences Advances Del-Zota Towards Accelerated FDA Approval for Duchenne Muscular Dystrophy
Stock NewsThemesAvidity Biosciences Advances Del-Zota Towards Accelerated FDA Approval for Duchenne Muscular Dystrophy

Avidity Biosciences Advances Del-Zota Towards Accelerated FDA Approval for Duchenne Muscular Dystrophy

Edgen StockEdgen Stock·Sep 12 2025, 04:00
Share to
Share to
Copy link
RNARNA+0.28%
Avidity Biosciences Advances Del-Zota Towards Accelerated FDA Approval for Duchenne Muscular Dystrophy
source:
[1] Avidity Biosciences: 'Strong Buy' Based On Accelerated Approval Filing For Del-Zota (RNA) (https://seekingalpha.com/article/4822205-avid ...)[2] Avidity Biosciences: Maintaining 'Strong Buy' Rating Based On Accelerated Approval Filing For Del-Zota - Seeking Alpha (https://seekingalpha.com/article/4636000-avid ...)[3] KalVista Pharmaceuticals Provides Operational Update and Reports Fiscal Quarter Financial Results (https://vertexaisearch.cloud.google.com/groun ...)

Related News

Babcock & Wilcox Secures $40M Refinery Contract
Dec 19 2025, 22:38

Babcock & Wilcox Secures $40M Refinery Contract

Babcock & Wilcox announced on December 19, 2025, that it secured a $40 million contract to supply its Wet Gas Scrubbing technology to a Canadian petroleum refinery, major Canadian petroleum refinery.

Tesla Profits Plunge 53% as Politics Cost 1.26M Sales
Dec 19 2025, 22:29

Tesla Profits Plunge 53% as Politics Cost 1.26M Sales

A Yale study finds Elon Musk's political stance cost Tesla 1.26 million car sales, contributing to a profit drop to $7.1 billion in 2024 from $15 billion in 2023.

Mizuho Lifts Tesla Target to $530 on Robotaxi Hopes
Dec 19 2025, 22:27

Mizuho Lifts Tesla Target to $530 on Robotaxi Hopes

On December 16, Mizuho increased its price target for Tesla to $530, citing growing confidence in the automaker's future robotaxi business.